Related Experiment Video
Updated: Aug 24, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Sex and Gender Differences in Heart Failure
Vera Regitz-Zagrosek1,2,3
1Berlin Institute for Gender in Medicine, Charité Universitätsmedizin, Berlin, Germany.
Sex significantly impacts heart failure (HF) presentation and treatment. Women experience different HF types and respond uniquely to therapies, highlighting the need for sex-specific research and care.
Area of Science:
- Cardiology
- Sex-based Medicine
- Translational Research
Background:
- Heart failure (HF) exhibits distinct sex-based phenotypes, with preserved ejection fraction (EF) more common in women and reduced EF (HFrEF) in men.
- Women with HF generally have better survival rates and lower risks of sudden death compared to men.
- Etiologies differ, with ischemia prevalent in men, while hypertension and diabetes are more significant contributors in women.
Purpose of the Study:
- To explore the sex-specific differences in heart failure pathophysiology, clinical presentation, and therapeutic responses.
- To emphasize the need for sex-disaggregated data in clinical trials and research.
- To highlight unique HF conditions in women, such as Takotsubo and peripartum cardiomyopathy.
Main Methods:
- Review of existing literature on sex differences in heart failure.
- Analysis of epidemiological data regarding HF prevalence and outcomes by sex.
- Examination of pharmacological responses to HF therapies based on sex.
Main Results:
- Women exhibit greater left ventricular stiffness and higher EF, potentially due to age-related fibrosis and hormonal influences.
- Estrogen's differential effect on collagen production in male and female cardiac fibroblasts noted.
- Metabolic profiles and responses to therapies like sacubitril-valsartan show significant sex-based variations.
Conclusions:
- Sex is a critical determinant in heart failure, influencing disease mechanisms, progression, and treatment efficacy.
- Current research and clinical trials inadequately report sex-specific outcomes, hindering personalized medicine.
- Further investigation into sex differences is essential for advancing heart failure management and improving patient outcomes.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions

